GLAND PHARMA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,885 INR | +4.98% |
|
+5.92% | -1.98% |
| 08:32am | Gland Pharma Posts Surge in Fiscal Q4 Consolidated Net Profit | MT |
| 05-07 | Gland Pharma Gets US FDA's Approval for Generic ALS Drug | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 723B | ||||||
| 595B | ||||||
| 369B | ||||||
| 332B | ||||||
| 282B |
